| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-13 11:50:25 UTC |
|---|
| Update Date | 2023-02-21 17:29:05 UTC |
|---|
| HMDB ID | HMDB0041965 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | O-Toluidine |
|---|
| Description | The chemical properties of the toluidines are quite similar to those of aniline and toluidines have properties in common with other aromatic amines. Due to the amino group bonded to the aromatic ring, the toluidines are weakly basic. None of the toluidines is very soluble in pure water, but will become soluble if the aqueous solution is acidic due to formation of ammonium salts, as usual for organic amines. At room temperature and pressure, ortho- and meta-toluidines are viscous liquids, but para-toluidine is a flaky solid. This can be explained by the fact that the p-toluidine molecules are more symmetrical and fit into a crystalline structure more easily. p-Toluidine can be obtained from reduction of p-nitrotoluene. p-Toluidine reacts with formaldehyde to form Troger's base. |
|---|
| Structure | InChI=1S/C7H9N/c1-6-4-2-3-5-7(6)8/h2-5H,8H2,1H3 |
|---|
| Synonyms | | Value | Source |
|---|
| 1-Amino-2-methylbenzene | ChEBI | | 1-Methyl-2-aminobenzene | ChEBI | | 2-Amino-1-methylbenzene | ChEBI | | 2-Aminotoluene | ChEBI | | 2-Methyl-1-aminobenzene | ChEBI | | 2-Methylbenzamine | ChEBI | | 2-Methylbenzenamine | ChEBI | | 2-Toluidine | ChEBI | | O-Aminotoluene | ChEBI | | O-Methylaniline | ChEBI | | O-Methylbenzenamine | ChEBI | | O-Tolylamine | ChEBI | | 2-Methyl-aniline | HMDB | | 2-Methyl-benzenamine | HMDB | | 2-Methylaniline | HMDB, MeSH | | 2-Methylphenylamine (acd/name 4.0) | HMDB | | O-Toluide | HMDB | | O-Toluidin | HMDB | | O-Toluidine (acd/name 4.0) | HMDB | | O-Toluidyna | HMDB | | ortho-Toluidine | HMDB, MeSH | | Rcra waste number u328 | HMDB | | 2-Toluidine sulfate | MeSH | | 2-Toluidine hydrochloride | MeSH | | 2-Toluidine perchlorate | MeSH | | 2-Toluidine, (ar)-isomer | MeSH | | 2-Toluidine, lithium salt | MeSH |
|
|---|
| Chemical Formula | C7H9N |
|---|
| Average Molecular Weight | 107.1531 |
|---|
| Monoisotopic Molecular Weight | 107.073499293 |
|---|
| IUPAC Name | 2-methylaniline |
|---|
| Traditional Name | toluidine |
|---|
| CAS Registry Number | 95-53-4 |
|---|
| SMILES | CC1=CC=CC=C1N |
|---|
| InChI Identifier | InChI=1S/C7H9N/c1-6-4-2-3-5-7(6)8/h2-5H,8H2,1H3 |
|---|
| InChI Key | RNVCVTLRINQCPJ-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as aminotoluenes. These are organic aromatic compounds containing a benzene that carries a single methyl group and one amino group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Benzene and substituted derivatives |
|---|
| Sub Class | Toluenes |
|---|
| Direct Parent | Aminotoluenes |
|---|
| Alternative Parents | |
|---|
| Substituents | - Aminotoluene
- Aniline or substituted anilines
- Organic nitrogen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Primary amine
- Organonitrogen compound
- Amine
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Liquid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | -16.3 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 16.6 mg/mL at 25 °C | Not Available | | LogP | 1.32 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 2.32 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 11.9046 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.35 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1257.0 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 420.0 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 125.8 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 271.6 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 73.5 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 326.1 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 394.4 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 132.1 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 989.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 313.0 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 906.5 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 303.6 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 341.4 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 402.3 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 234.7 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 85.9 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| O-Toluidine,1TMS,isomer #1 | CC1=CC=CC=C1N[Si](C)(C)C | 1228.9 | Semi standard non polar | 33892256 | | O-Toluidine,1TMS,isomer #1 | CC1=CC=CC=C1N[Si](C)(C)C | 1232.7 | Standard non polar | 33892256 | | O-Toluidine,2TMS,isomer #1 | CC1=CC=CC=C1N([Si](C)(C)C)[Si](C)(C)C | 1288.4 | Semi standard non polar | 33892256 | | O-Toluidine,2TMS,isomer #1 | CC1=CC=CC=C1N([Si](C)(C)C)[Si](C)(C)C | 1389.3 | Standard non polar | 33892256 | | O-Toluidine,1TBDMS,isomer #1 | CC1=CC=CC=C1N[Si](C)(C)C(C)(C)C | 1481.8 | Semi standard non polar | 33892256 | | O-Toluidine,1TBDMS,isomer #1 | CC1=CC=CC=C1N[Si](C)(C)C(C)(C)C | 1446.3 | Standard non polar | 33892256 | | O-Toluidine,2TBDMS,isomer #1 | CC1=CC=CC=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1714.2 | Semi standard non polar | 33892256 | | O-Toluidine,2TBDMS,isomer #1 | CC1=CC=CC=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1794.4 | Standard non polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental GC-MS | GC-MS Spectrum - O-Toluidine EI-B (Non-derivatized) | splash10-0a4i-5900000000-ee7fe6869533a6858f94 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - O-Toluidine EI-B (Non-derivatized) | splash10-0a4i-6900000000-68480e71423ffd272f9d | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - O-Toluidine EI-B (Non-derivatized) | splash10-0a4i-5900000000-ee7fe6869533a6858f94 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - O-Toluidine EI-B (Non-derivatized) | splash10-0a4i-6900000000-68480e71423ffd272f9d | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - O-Toluidine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4i-7900000000-661d661a8df390a5081a | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - O-Toluidine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | MS | Mass Spectrum (Electron Ionization) | splash10-0a4i-5900000000-f04208345695340d7d9f | 2014-09-20 | Not Available | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - O-Toluidine ESI-ITFT , positive-QTOF | splash10-052f-9500000000-1da8fd338a6e499f67b8 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - O-Toluidine ESI-ITFT , positive-QTOF | splash10-0006-9000000000-e311b1811a6d3a59268a | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - O-Toluidine ESI-ITFT , positive-QTOF | splash10-0006-9000000000-1c57a6134b99aef82338 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - O-Toluidine ESI-ITFT , positive-QTOF | splash10-0006-9000000000-1843caa3f26f243817eb | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - O-Toluidine ESI-ITFT , positive-QTOF | splash10-0006-9000000000-e44d3c280fede3615b13 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - O-Toluidine ESI-ITFT , positive-QTOF | splash10-0a4i-0900000000-3cd853f6114cba521a13 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - O-Toluidine ESI-ITFT , positive-QTOF | splash10-0a4i-0900000000-b4d6fdb227e5b9621611 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - O-Toluidine ESI-ITFT , positive-QTOF | splash10-0a4i-2900000000-2f6e21711a72ca0477a8 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - O-Toluidine ESI-ITFT , positive-QTOF | splash10-0a4l-7900000000-c0f650fc70669757d0e6 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - O-Toluidine ESI-ITFT , positive-QTOF | splash10-0006-9400000000-bcd0a7b786b0217f655c | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - O-Toluidine ESI-ITFT , positive-QTOF | splash10-0006-9100000000-4312ff484c74be498895 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - O-Toluidine ESI-ITFT , positive-QTOF | splash10-0006-9000000000-4e34b2af3ed0df18b3b2 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - O-Toluidine ESI-ITFT , positive-QTOF | splash10-0006-9000000000-8facfe25a950827aa822 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - O-Toluidine ESI-ITFT , positive-QTOF | splash10-00kf-9000000000-978c9096a7e167a13bc3 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - O-Toluidine APCI-ITFT , positive-QTOF | splash10-0006-9000000000-59dad1d5d1802381bc6a | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - O-Toluidine APCI-ITFT , positive-QTOF | splash10-0006-9000000000-31d6e4c02cb1c35d7e2d | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - O-Toluidine APCI-ITFT , positive-QTOF | splash10-0006-9000000000-ee83d5d19af792cc8783 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - O-Toluidine APCI-ITFT , positive-QTOF | splash10-0006-9000000000-4faf1f04148279e9331a | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - O-Toluidine APCI-ITFT , positive-QTOF | splash10-0006-9000000000-4b5d5bc4707cf980910e | 2017-09-14 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - O-Toluidine 10V, Positive-QTOF | splash10-0a4i-0900000000-a715018533d6dc4e8052 | 2015-04-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - O-Toluidine 20V, Positive-QTOF | splash10-0a4i-1900000000-0370f837fa70b324ecfe | 2015-04-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - O-Toluidine 40V, Positive-QTOF | splash10-0fc0-9000000000-f0196e420945b736f49b | 2015-04-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - O-Toluidine 10V, Negative-QTOF | splash10-0a4i-0900000000-1000f1353d3e835b7498 | 2015-04-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - O-Toluidine 20V, Negative-QTOF | splash10-0a4i-0900000000-3b8b19ef01e3a1cb8a0d | 2015-04-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - O-Toluidine 40V, Negative-QTOF | splash10-0a4i-9800000000-aecf80c0988d8154d1e9 | 2015-04-25 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum |
IR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-04 | FELIX lab | View Spectrum | | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-04 | FELIX lab | View Spectrum | | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-04 | FELIX lab | View Spectrum |
|
|---|
| General References | - Lawson NS, Haven GT, Moore TD: Long-term stability of glucose in lyophilized quality control serum. A study utilizing data from the Quality Assurance Service (QAS) Program of the College of American Pathologists. Am J Clin Pathol. 1978 Sep;70(3 Suppl):523-31. [PubMed:707419 ]
- Roberts MC, Norman P: A re-evaluation of the D (+) xylose absorption test in the horse. Equine Vet J. 1979 Oct;11(4):239-43. [PubMed:540633 ]
- Oganov RG, Aleksandrov AA, Vinogradova IV: [Sensitivity to insulin in acute myocardial infarct]. Kardiologiia. 1977 Jan;17(1):89-94. [PubMed:857071 ]
- Preece MA, Newall RG: Dextrostix-Eyetone in the insulin hypoglycaemia test. Br Med J. 1977 Jul 16;2(6080):152-4. [PubMed:871822 ]
- Kiang SW, Kuan JW, Kuan SS, Guilbault GG: Measurement of glucose in plasma, with use of immobilized glucose oxidase and peroxidase. Clin Chem. 1976 Aug;22(8):1378-82. [PubMed:949848 ]
- Briggs TB, Smith RR: Exertional rhabdomyolysis associated with decerebrate posturing. Neurosurgery. 1986 Aug;19(2):297-9. [PubMed:3748364 ]
- Akmal M, Massry SG: Peripheral nerve damage in patients with nontraumatic rhabdomyolysis. Arch Intern Med. 1983 Apr;143(4):835-6. [PubMed:6301396 ]
- Schulze VE Jr: Rhabdomyolysis as a cause of acute renal failure. Postgrad Med. 1982 Dec;72(6):145-7, 150-8. [PubMed:7145778 ]
- Ralph D: Rhabdomyolysis and acute renal failure. JACEP. 1978 Mar;7(3):103-6. [PubMed:633672 ]
- Yasunaga Y, Nakanishi H, Naka N, Miki T, Tsujimura T, Itatani H, Okuyama A, Aozasa K: Alterations of the p53 gene in occupational bladder cancer in workers exposed to aromatic amines. Lab Invest. 1997 Dec;77(6):677-84. [PubMed:9426406 ]
- Viner BM, Kisel' VL, Krendal' FP, Rubtsova ER: [A modification of the ortho-toluidine method for determining glucose in the blood]. Eksp Klin Farmakol. 1993 May-Jun;56(3):62-4. [PubMed:8219998 ]
- Line RL, Rust GS: Acute exertional rhabdomyolysis. Am Fam Physician. 1995 Aug;52(2):502-6. [PubMed:7625324 ]
- De La Morena Garcia E, Garcia Lomas Pico LA, Salas Salas FJ, Cantero Garcia-Arenal L: [Comparison of the blood glucose levels obtained by the Reflomat-Glucose-Reflotest and the orthotoluidine method]. Rev Clin Esp. 1980 Mar 31;156(6):403-5. [PubMed:7394218 ]
- Milne CJ: Rhabdomyolysis, myoglobinuria and exercise. Sports Med. 1988 Aug;6(2):93-106. [PubMed:3062736 ]
- Sefer S, Degoricija V, Bilic B, Trotic R, Milanovic-Stipkovic B, Ratkovi-Gusic I, Kes P: Acute carbon monoxide poisoning as the cause of rhabdomyolysis and acute renal failure. Acta Med Croatica. 1999;53(4-5):199-202. [PubMed:10914136 ]
- Tkaczewski W, Chojnacki J, Bogoniowska Z: The effect of glucagon on the blood levels of gastrin, insulin and glucose in patients with gastric and duodenal ulcers. Acta Hepatogastroenterol (Stuttg). 1979 Oct;26(5):396-8. [PubMed:525217 ]
- Klimek K, Gdakowicz B, Gregorczyk J: [Ability of the tissues to assimilate glucose and the pyruvate and lactate levels after intravenous glucose load in patients with peripheral facial paralysis]. Neurol Neurochir Pol. 1985 Sep-Oct;19(5):395-400. [PubMed:3831793 ]
- Polushina ND: [The effect of mineral water on serotonin and insulin production (an experimental study)]. Vopr Kurortol Fizioter Lech Fiz Kult. 1998 Jul-Aug;(4):9-10. [PubMed:9855765 ]
- Varkonyi T, Balint GA, Csati S, Varro V: Laboratory method for measuring small amounts of tissue glycogen. Biochem Exp Biol. 1980;16(2):175-9. [PubMed:7348198 ]
- Oganov RG, Aleksandrov AA, Vinogradova NV, Korochkin IM: [Content of immunoreactive insulin and catecholamines in blood plasma and disorders of carbohydrate metabolism in patients with myocardial infarct]. Kardiologiia. 1975 Sep;15(9):91-100. [PubMed:1230533 ]
|
|---|